From Leflunomide to Teriflunomide: Drug Development and Immunosuppressive Oral Drugs in the Treatment of Multiple Sclerosis
Journal:
Current Neuropharmacology
Volume:
15
Page:
874-891
Author(s):
Lilian Aly, Bernhard Hemmer* and Thomas Korn*
Current Progresses in Metal-based Anticancer Complexes as Mammalian TrxR Inhibitors
Journal:
Anti-Cancer Agents in Medicinal Chemistry
Volume:
17
Page:
1046-1069
Author(s):
Yizhe Cheng* and Yan Qi
FLT3 Inhibitors in the Management of Acute Myeloid Leukemia
Journal:
Anti-Cancer Agents in Medicinal Chemistry
Volume:
17
Page:
1028-1032
Author(s):
E. Zappone*, M. Defina, L. Aprile, G. Bartalucci, A. Gozzetti and M. Bocchia
Bruton Kinase Inhibitors in Chronic Lymphocytic Leukemia
Journal:
Anti-Cancer Agents in Medicinal Chemistry
Volume:
17
Page:
1040-1045
Author(s):
Alessandro Gozzetti*, Veronica Candi, Corrado Zuanelli Brambilla, Giulia Papini, Alberto Fabbri and Monica Bocchia
New N’-Arylidene-2-[(4-Nitrophenyl)Piperazın-1-yl]Acetohydrazide Derivatives: Synthesis and Anticancer Activity Investigation
Journal:
Letters in Drug Design & Discovery
Volume:
14
Page:
910-917
Author(s):
Leyla Yurttas*, Zafer A. Kaplancikli and Sennur Gorgulu-Kahyaoglu
CEBP Epigenetic Dysregulation as a Drug Target for the Treatment of Hematologic and Gynecologic Malignancies
Journal:
Current Drug Targets
Volume:
18
Page:
1142-1151
Author(s):
Chengming Sun, Ping Duan and Caifu Luan*
Sporadic Porphyria in a Patient with Stage II Melanoma Treated with Interferon α
Journal:
Current Drug Safety
Volume:
12
Page:
131-133
Author(s):
V. Reymann*, C. Girard, O. Dereure, B. Guillot and A. Du Thanh
Development of Doxorubicin Quantification by Reductive Amination
Journal:
Current Analytical Chemistry
Volume:
13
Page:
270-276
Author(s):
Yi-Reng Lin, Chia-En Wu, Mei-Fang Huang, You-Ying Wu, Jing-Heng Huang, Meng-Chieh Liu, Ziyu Chen, Yow-Ling Shiue and Shih-Shin Liang*
Topoisomerase II Inhibitors and Poisons, and the Influence of Cell Cycle Checkpoints
Journal:
Current Medicinal Chemistry
Volume:
24
Page:
1504-1519
Author(s):
Nicholas D`Arcy and Brian Gabrielli*
DNA-Damaging Anticancer Drugs – A Perspective for DNA Repair- Oriented Therapy
Journal:
Current Medicinal Chemistry
Volume:
24
Page:
1488-1503
Author(s):
Janusz Blasiak*